This narrative review synthesizes the pulmonary artery pressure (PAP) monitoring evidence base and proposes an artificial intelligence (AI)-supported framework for patient selection and adaptive surveillance as implanted sensors enter reimbursed care.
📅 Journal publication: Oct 19, 2026·Last updated: Nov 2, 2026
AI-driven heart failure monitoring may redefine patient management.
Implanted pulmonary artery pressure monitoring aids in early detection of worsening heart failure, potentially reducing hospitalizations. Pulmonary artery pressure-guided management effectively lowers heart failure hospitalizations, but additional risk persists; AI could further enhance outcomes. AI-based personalized patient management may optimize monitoring and treatment in heart failure, but this concept is not yet clinical practice. AI could personalize heart failure management by modeling individual risks and optimizing monitoring.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.